Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Kayal
Matthew Joseph Kayal, Franklin, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20080254272 | MULTI-LAYER SHEET FOR USE IN ELECTRO-OPTIC DISPLAYS - A multi-layer film ( | 10-16-2008 |
| 20100165446 | COMPONENTS AND METHODS FOR USE IN ELECTRO-OPTIC DISPLAYS - A display assembly comprises a backplane assembly comprising a plurality of spaced backplane areas, each backplane area comprising a plurality of electrodes, the backplane areas being separated by gutter areas free from electrodes; an adhesive layer overlying the plurality of spaced backplane areas; and a layer of a solid electro-optic medium overlying the adhesive layer in the plurality of spaced backplane areas. The display sub-assembly can be produced via a single lamination and severed to form a plurality of separate electro-optic displays. Processes for producing the display assembly are also described. | 07-01-2010 |
Prasheel Kayal, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20090248586 | MANAGING CONSISTENT INTERFACES FOR BUSINESS OBJECTS ACROSS HETEROGENEOUS SYSTEMS - A business object model, which reflects data that is used during a given business transaction, is utilized to generate interfaces. This business object model facilitates commercial transactions by providing consistent interfaces that are suitable for use across industries, across businesses, and across different departments within a business during a business transaction. In some operations, software creates, updates, or otherwise processes information related to a cost model, a current account contract, and/or a collateral constellation business object. | 10-01-2009 |
Samer Kayal, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20090275499 | NONSTRUCTURAL PROTEIN NS1 AS A NOVEL THERAPEUTIC TARGET AGAINST FLAVIVIRUSES - The secretion or biological activity of Flaviviruses, as well as the biological activity of NS1 protein from Flavivirus-infected cells, can be inhibited by contacting the cells or the protein with cholesterol inhibitors, sphingolipid inhibitors, glycosphingolipid inhibitors, or molecules comprising an amphipathic, amphiphilic, or hydrophobic region which interacts with NS1 protein. | 11-05-2009 |